Inspire Medical Systems (NASDAQ:INSP) Director Sells $12,806,040.16 in Stock

Inspire Medical Systems (NASDAQ:INSP) Director Joyce Erony sold 191,192 shares of Inspire Medical Systems stock in a transaction on Wednesday, July 10th. The stock was sold at an average price of $66.98, for a total transaction of $12,806,040.16. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Joyce Erony also recently made the following trade(s):

  • On Friday, May 31st, Joyce Erony sold 66,568 shares of Inspire Medical Systems stock. The stock was sold at an average price of $55.75, for a total transaction of $3,711,166.00.
  • On Wednesday, May 29th, Joyce Erony sold 44,053 shares of Inspire Medical Systems stock. The stock was sold at an average price of $54.27, for a total transaction of $2,390,756.31.
  • On Thursday, May 23rd, Joyce Erony sold 39,379 shares of Inspire Medical Systems stock. The stock was sold at an average price of $54.52, for a total transaction of $2,146,943.08.

Shares of INSP stock opened at $67.15 on Friday. Inspire Medical Systems has a 1-year low of $35.43 and a 1-year high of $69.71. The business’s fifty day moving average is $58.68.

Inspire Medical Systems (NASDAQ:INSP) last announced its quarterly earnings data on Tuesday, May 7th. The company reported ($0.35) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.39) by $0.04. The company had revenue of $16.30 million for the quarter, compared to analyst estimates of $17.79 million. Inspire Medical Systems’s quarterly revenue was up 63.0% on a year-over-year basis.

Several equities research analysts recently issued reports on the stock. Zacks Investment Research raised shares of Vistra Energy from a “hold” rating to a “buy” rating and set a $25.00 price target on the stock in a research note on Saturday. Bank of America reaffirmed a “sell” rating on shares of Deutsche Bank in a research note on Monday, July 8th. Two investment analysts have rated the stock with a sell rating, one has issued a hold rating and two have issued a buy rating to the company. Inspire Medical Systems currently has a consensus rating of “Hold” and a consensus target price of $57.20.

A number of hedge funds have recently made changes to their positions in the business. TD Asset Management Inc. grew its holdings in Inspire Medical Systems by 3.1% during the 1st quarter. TD Asset Management Inc. now owns 9,861 shares of the company’s stock worth $560,000 after acquiring an additional 300 shares in the last quarter. Summit Partners Public Asset Management LLC grew its holdings in Inspire Medical Systems by 2.0% during the 4th quarter. Summit Partners Public Asset Management LLC now owns 28,522 shares of the company’s stock worth $1,205,000 after acquiring an additional 566 shares in the last quarter. FinTrust Capital Advisors LLC acquired a new position in Inspire Medical Systems during the 1st quarter worth $34,000. Capital Financial Planning LLC acquired a new position in Inspire Medical Systems during the 4th quarter worth $27,000. Finally, Legal & General Group Plc grew its holdings in Inspire Medical Systems by 57.7% during the 4th quarter. Legal & General Group Plc now owns 1,843 shares of the company’s stock worth $78,000 after acquiring an additional 674 shares in the last quarter.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

Recommended Story: How much can an individual set aside as a catch-up contribution?

Insider Buying and Selling by Quarter for Inspire Medical Systems (NASDAQ:INSP)

Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.